Difference between revisions of "Schmoll D"
From Bioblast
Beno Marija (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 16: | Line 16: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | == Participated at== | ||
::::* [[IOC54]] | ::::* [[IOC54|IOC54 Schroecken AT]] | ||
Latest revision as of 16:45, 12 February 2018
| Name | Schmoll Dieter, Dr. |
|---|---|
| Institution | Sanofi-Aventis Deutschland GmbH
R&D DIAB Div. / Innovation&ext.Network. FF |
| Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
| City | Frankfurt am Main |
| State/Province | |
| Country | Germany |
| [email protected] | |
| Weblink | www.sanofi.de |
| O2k-Network Lab | DE Frankfurt Schmoll D |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |
